The purpose of this study is to find out if a medicine called finerenone in combination with a medicine called empagliflozin is a safe and effective treatment for people that chronic kidney disease and type 2 diabetes.
Study visits will be like regular doctor appointments. At these visits, we will measure your vital signs (blood pressure, weight, height), conduct an ECG (test to measure heart function), the study doctor will complete a brief physical exam, and we will collect blood and urine samples.
$75
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Amy Mottl
Medicine-Nephrology
Clinical or Medical
Interventional
Diabetes
Kidneys and Liver
Rare Diseases
22-1479